Log In
Print
BCIQ
Print
Print this Print this
 

Restylane

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionHyaluronic acid dermal filler
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsLip augmentation
Regulatory Designation

Partner

Ipsen Group; Valeant Pharmaceuticals International Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$2,500.0M

$2,277.0M

$223.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today